CMS Enrollment Moratoria and Home Health & Hospice M&A: A 2026 Seller's Guide

Most home health and hospice owners think of CMS enrollment rules as a back-office compliance matter. In M&A, they are anything but. A single regulatory lever — the temporary enrollment moratorium — can freeze new competitors out of an entire state and quietly turn your Medicare certification into one of the most valuable, scarce assets a buyer can acquire.

This guide explains what CMS enrollment moratoria are, the history that every buyer’s diligence team already knows, what the 2026 environment looks like, and — most importantly — how a moratorium changes the value and structure of a home health or hospice sale.

---

What a CMS Enrollment Moratorium Actually Is

A CMS enrollment moratorium is a temporary freeze on the enrollment of new providers or suppliers of a specified type within a defined geography. The authority traces to Section 6401(a) of the Affordable Care Act, which added Section 1866(j)(7) to the Social Security Act and is implemented at 42 CFR 424.570.

The standard is deliberately broad. CMS may impose a moratorium when it determines there is a significant potential for fraud, waste, or abuse — typically signaled by a rapid, disproportionate growth in the number of providers of a given type in a market relative to beneficiary demand.

Three features matter for sellers:

• It targets new entrants, not incumbents. A moratorium blocks the door behind you. Agencies already enrolled and certified continue to operate and bill normally.
• It is geographic and provider-specific. A moratorium may apply statewide, metro-wide, to home health agencies, to certain DME suppliers, or to other provider types — independently of one another.
• It preserves changes of ownership. Moratoria have consistently carved out change-of-ownership (CHOW) transactions, which is the legal foundation for why M&A continues — and accelerates — during a freeze.

---

The History Buyers Already Know

Every sophisticated home health buyer underwrites moratorium risk because the sector has lived through it before:

Period	Action
July 2013	CMS imposes the first home health enrollment moratoria in the Miami and Chicago metro areas, plus ground-ambulance freezes in Houston.
2014	Moratoria extended and expanded to additional metros, including Dallas, Houston, and Detroit.
July 2016	CMS replaces the metro approach with statewide home health moratoria across Florida, Illinois, Michigan, and Texas.
2016–2018	Moratoria renewed in six-month increments.
January 2019	CMS lifts all enrollment moratoria, restoring new home health enrollment nationwide.

The lesson buyers drew from that cycle is simple: in a moratorium state, you could not build a new agency, so the only way in was to buy one. Agencies in Florida, Illinois, Michigan, and Texas commanded scarcity premiums precisely because the certification itself had become non-replicable.

---

The 2026 Environment

As of the most recent guidance, there is no broad, continuous national home health moratorium in effect; the 2016-era statewide freezes ended in January 2019. But two things keep this issue firmly on the table for 2026:

1. The authority never went away. CMS can reimpose a moratorium — by state, metro, or provider type — on short notice, and it continues to flag home health and hospice as elevated program-integrity priorities.
2. Hospice scrutiny has intensified. Explosive provider growth in several Sun Belt markets has driven aggressive CMS oversight of hospice enrollment, including enhanced screening and provisional periods of enhanced oversight for newly enrolling providers — the same conditions that historically preceded home health moratoria.

For owners, the practical takeaway is not to predict the exact date of the next freeze. It is to recognize that moratorium risk is asymmetric in the seller’s favor: if one is imposed in your market, demand for your already-certified agency rises sharply.

---

Why a Moratorium Is Bullish for Sellers

It is counterintuitive, but a regulatory freeze on your own industry usually increases what your business is worth. Here is the mechanism.

1. It fixes the supply of acquirable agencies. Buyers — private equity platforms, strategics, and regional operators — grow by entering and densifying markets. When de novo entry is blocked, the only path to growth in that market is acquisition. Fixed supply plus motivated, well-capitalized demand is the textbook setup for rising multiples.

2. It converts your certification into a scarce asset. Outside a moratorium, your Medicare certification is valuable but replicable; a competitor can enroll. Inside a moratorium, it is effectively non-replicable for the duration. That scarcity is real, and buyers pay for it.

3. It rewards clean compliance. Because new enrollment is frozen, buyers concentrate their capital on the limited pool of existing agencies — and they pay the strongest prices for the ones with clean billing histories, low audit exposure, and transferable provider numbers. (See our home care M&A due diligence checklist for what they scrutinize.)

This dynamic mirrors what we see in Certificate of Need (CON) states, where licensure scarcity drives premium valuations year-round. If you operate in a CON state, the two effects can compound. Our CON-state home health M&A guide covers that interaction in detail.

---

How a Moratorium Changes Deal Structure

When new enrollment is frozen, how you sell matters as much as whether you sell.

Stock and equity sales are favored

In a stock or equity transaction, the legal entity survives the sale, and with it the Medicare provider agreement and billing number. The buyer steps into an already-enrolled provider — no new enrollment required, no moratorium exposure. In a moratorium market, this is exactly what buyers want, and it gives sellers of well-run entities meaningful negotiating leverage.

Asset sales get complicated

In an asset sale, the buyer often must enroll or re-establish billing privileges for the acquired operations. A moratorium can block or delay that step, jeopardizing post-close billing continuity. Deals can still be structured around this — but the moratorium tilts the field decisively toward equity structures. Our breakdown of asset sale vs. stock sale in home care M&A explains the trade-offs.

CHOW execution becomes critical

Because the value is in the transferable provider number, flawless execution of the Change of Ownership (CHOW) process protects the entire thesis of the deal. Timing, successor-liability allocation, and accreditation transfer all have to be managed precisely. We cover the mechanics in our CMS Change of Ownership (CHOW) seller’s guide.

---

What Owners Should Do Now

Whether or not a moratorium is active in your market today, the right preparation is the same:

• Confirm your current status. Verify the enrollment-moratorium status for your provider type and state before going to market, and document your provider number, enrollment record, and accreditation as transferable assets.
• Keep billing compliance pristine. In a frozen market, buyers pay premiums for clean agencies and discount — or walk from — agencies with audit exposure. A quality of earnings and billing review before you sell protects your price.
• Structure for the provider number. Position the transaction to preserve and transfer your certification cleanly, which usually means an equity-oriented structure and a well-planned CHOW.
• Move when scarcity is highest. If a moratorium is imposed in your market, that is frequently the optimal moment to run a competitive process — buyer demand for your certification will rarely be stronger.

Hendon Partners advises owners of Medicare-certified home health agencies and hospice providers on exactly these dynamics — turning regulatory scarcity into competitive tension and a higher closing price. If you want to understand how the current enrollment environment affects the value of your agency specifically, book a free confidential valuation call.